Sari 59-801

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Sari 59-801 是一种新型口服有效降血糖化合物，似乎主要通过刺激胰岛素释放发挥作用。 SARI-59-801 比瘦同窝仔鼠 (ED25 = 131 mg/kg) 更能产生低血糖 (ED25 = 47 mg/kg)。

Sari 59-801 is a novel, orally effective hypoglycemic compound that appears to act largely by stimulation of insulin release. SARI-59-801 was more potent in producing hypoglycemia (ED25 = 47 mg/kg) than their lean littermates (ED25 = 131 mg/kg).(In Vivo):The 2-hr hypoglycemic ED25 in fasting mice was 110 mg/kg; the plasma insulin levels were increased, with an ED50 of 47 mg/kg. The significant hypoglycemic activity was observed 2 hr after oral administration of 59-801 to fasting rats (ED25 = 86 mg/kg), while plasma insulin was elevated by 62% at 100 mg/kg.

——

——

Sari-59-801

Others

Other Targets

5-HT

——

——

80565-58-8

313.401

C18H23N3O2

>98% (HPLC)

——

CCc1noc(C)c1-c1[nH]c2ccccc2c1C(O)CN(C)C

——

(-20℃)

With Ice Pack

≥ 2 years